GlassScriptPhysician profile
Stephen Stahr
NPI 1144458373
$11,893.72
in general payments reported to CMS, 2019-2025
39 companies · $2,691 in 2025
The $2,691 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,971 · 2020: $923 · 2021: $930 · 2022: $1,311 · 2023: $1,991 · 2024: $2,077 · 2025: $2,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,357 · Education: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,356.95 |
| Education | $401.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,877.94 | 2019-2025 | Skyrizi, Rinvoq |
| Ucb, INC. | $1,285.81 | 2019-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $1,253.32 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $1,097.10 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $692.07 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $647.17 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $608.39 | 2019-2025 | Ilumya |
| Genzyme Corporation | $577.39 | 2019-2025 | |
| Pfizer INC. | $521.24 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $472.94 | 2022-2025 | Sotyktu |
| Amgen INC. | $426.12 | 2020-2025 | Otezla, Otezla |
| Leo Pharma INC. | $281.02 | 2019-2025 | Adbry, Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $251.82 | 2019-2025 | Jublia |
| Almirall LLC | $246.65 | 2019-2021 | |
| Galderma Laboratories, L.P. | $241.64 | 2019-2025 | Nemluvio |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Stahr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.